Testing you can trust
Recent independent assessment data has highlighted significant differences in the performance of EMA antibodies currently available on the market. According to a recent NordiQC evaluation, some commonly used EMA clones failed to achieve satisfactory staining performance, prompting recommendations for laboratories to consider more robust alternatives.
Why Consider Cell Marque EMA (clone E29)?
- Independently assessed by NordiQC
- Achieved Optimal or Good assessment scores
- Available in both concentrated and prediluted formats
- Consistent and reliable staining performance
- Ideal for laboratories seeking confidence in diagnostic results
Â
The NordiQC assessment specifically reported that a widely used competitor EMA clone did not produce sufficient results and recommended that laboratories consider changing to a more robust antibody. In contrast, Cell Marque’s EMA clone E29 achieved optimal or good performance ratings, demonstrating dependable staining quality across tested protocols.
Â
Cell Marque EMA (E29)
Epithelial Membrane Antigen (EMA) is a well-established marker used in the evaluation of a wide range of epithelial neoplasms. Selecting a high-performing antibody clone is critical to ensuring reliable staining quality and diagnostic confidence.
Read the NordiQC Assessment Report
If you would like to evaluate Cell Marque EMA Clone E29 in your laboratory, contact us for further information, pricing, or validation support.
Contact us for an evaluation
Request a Quote